biotechnology

Simulaatio lääkekehitysalan kannattavuudesta ja riskeistä

Tässä tutkimuksessa simuloidaan lääkekehitykseen suuntautuneiden pienten ja keskisuurten biotekniikkayritysten tulevaisuutta, erityispainopisteenä kansantaloudelliset implikaatiot. Simulaatiossa huomioidaan vaihtoehtoisia kehityspolkuja, joiden avulla on arvioitu erilaisten liiketoimintamallien toimialakohtainen kasvuvaikutus. Koska simulaation lähtökohtana ovat yhtiöiden vuonna 2004 ilmaisemat kehityskelpoiset hankkeet, laskee projektien lukumäärä simulaation myöhemmässä vaiheessa verraten pieneksi ja markkina-arvon kehitys riippuu täysin siitä, mitkä yksittäiset projektit pääsevät eteenpäin. Simulaatio

Riskirahoituksen merkitys biotekniikka-alalla: Pääomasijoittajien vertailu yritysten näkökulmasta

The paper reports an empirical study on the overall importance and non-financial value-added provided by Venture Capital (VC) investors to their investee firms in biotechnology. The study compares the characteristics of firms that have obtained VC funding with those of firms that have not. Furthermore, it pays attention to the activities and non-financial value-added by

Patent citations indicating present value of the biotechnology business

Patents form a central pathway for capturing the value of intangible assets in a knowledge-intensive business. Patents can potentially generate and support earnings in two ways : they can be traded or licensed out, and they can provide critical protection for core production technologies or products that are to be traded. Recent patent valuation literature

Coaching Small Biotech Companies into Success: The Value-adding Function of VC

The paper reports an empirical study on the non-financial value-added provided by Venture Capital investors to their investee firms. This study will use a four-class grouping of the various non-financial value-adding capabilities provided by VC firms, namely, scouting, monitoring, signalling and value-adding services. The study examines biotechnology industry in Finland. Finland has a dual system

The Perceived Value-added of Venture Capital Investors. Evidence from Finnish Biotechnology Industry

This study focuses on the non-financial value-added of venture capital investors (VCs) as perceived by the CEOs of Finnish biotechnology companies. It pays attention to differences in the value-added between informal venture capitalists, private sector venture capitalists and public sector venture capital organizations. In addition, this study pays attention to value-adding mechanisms which venture capitalists

Helsingin seudun klusterit sekä erikoistuminen bioteknologiaan ja logistiikkaan

Production and employment have grown faster in the Helsinki Region and in the Province of Uusimaa compared to growth rates for Finland as a whole. At the same time, the extent of specialisation has diminished. The production structure of this region is now much more similar to that of the overall Finnish economy than it